Report Thumbnail
Product Code LP0912613485YMD
Published Date 2024/5/1
English110 PagesGlobal

Global Dipotassium Glycyrrhizinate Market Growth 2024-2030Food_Beverage_Agriculture Market


Report Thumbnail
Product Code LP0912613485YMD◆The May 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/5/1
English 110 PagesGlobal

Global Dipotassium Glycyrrhizinate Market Growth 2024-2030Food_Beverage_Agriculture Market



Abstract


Summary

Dipotassium Glycyrrhizinate is a dipotassium salt of Glycyrrhizic Acid. It can be used as a flavoring agent and a skin conditioning agent with anti-allergic and anti-inflammatory properties.
The global Dipotassium Glycyrrhizinate market size is projected to grow from US$ 43.6 million in 2024 to US$ 64.1 million in 2030; it is expected to grow at a CAGR of 6.6% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Dipotassium Glycyrrhizinate Industry Forecast” looks at past sales and reviews total world Dipotassium Glycyrrhizinate sales in 2023, providing a comprehensive analysis by region and market sector of projected Dipotassium Glycyrrhizinate sales for 2024 through 2030. With Dipotassium Glycyrrhizinate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dipotassium Glycyrrhizinate industry.
This Insight Report provides a comprehensive analysis of the global Dipotassium Glycyrrhizinate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dipotassium Glycyrrhizinate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dipotassium Glycyrrhizinate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dipotassium Glycyrrhizinate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dipotassium Glycyrrhizinate.
The core manufacturers of Dipotassium Glycyrrhizinate in the world include MAFCO Worldwide, Nikko Chemicals and GfN Selco. The top three companies have a market share of about 63%. China is the world's largest Dipotassium Glycyrrhizinate market with a market share of about 50%, followed by Japan and Europe with a market share of 27% and 13%, respectively. In terms of product type, Food Grade is the largest segment with approximately 22% market share. In terms of application, Cosmetic and Skin Care is the largest downstream segment, accounting for about 67% of the market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Dipotassium Glycyrrhizinate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Food Grade
Pharma Grade
Others
Segmentation by Application:
Pharma and Healthcare
Food and Feed Additives
Cosmetic and Skin Care
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GfN Selco
Alps Pharmaceutical
Nikko Chemicals
Fanzhi Pharmaceutical
MAFCO Worldwide
Shaanxi Jintai Biological Engineering
Jiangsu Tiansheng Pharmaceutical
Qinghai Lake Pharmaceutical
VITAL-CHEM Zhuhai
Shaanxi Fujie Pharmaceutical
Qingdao Taitong Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Dipotassium Glycyrrhizinate market?
What factors are driving Dipotassium Glycyrrhizinate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dipotassium Glycyrrhizinate market opportunities vary by end market size?
How does Dipotassium Glycyrrhizinate break out by Type, by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Dipotassium Glycyrrhizinate Annual Sales 2019-2030
      • 2.1.2 World Current & Future Analysis for Dipotassium Glycyrrhizinate by Geographic Region, 2019, 2023 & 2030
      • 2.1.3 World Current & Future Analysis for Dipotassium Glycyrrhizinate by Country/Region, 2019, 2023 & 2030
    • 2.2 Dipotassium Glycyrrhizinate Segment by Type
      • 2.2.1 Food Grade
      • 2.2.2 Pharma Grade
      • 2.2.3 Others
    • 2.3 Dipotassium Glycyrrhizinate Sales by Type
      • 2.3.1 Global Dipotassium Glycyrrhizinate Sales Market Share by Type (2019-2024)
      • 2.3.2 Global Dipotassium Glycyrrhizinate Revenue and Market Share by Type (2019-2024)
      • 2.3.3 Global Dipotassium Glycyrrhizinate Sale Price by Type (2019-2024)
    • 2.4 Dipotassium Glycyrrhizinate Segment by Application
      • 2.4.1 Pharma and Healthcare
      • 2.4.2 Food and Feed Additives
      • 2.4.3 Cosmetic and Skin Care
      • 2.4.4 Others
    • 2.5 Dipotassium Glycyrrhizinate Sales by Application
      • 2.5.1 Global Dipotassium Glycyrrhizinate Sale Market Share by Application (2019-2024)
      • 2.5.2 Global Dipotassium Glycyrrhizinate Revenue and Market Share by Application (2019-2024)
      • 2.5.3 Global Dipotassium Glycyrrhizinate Sale Price by Application (2019-2024)
  • 3 Global by Company

    • 3.1 Global Dipotassium Glycyrrhizinate Breakdown Data by Company
      • 3.1.1 Global Dipotassium Glycyrrhizinate Annual Sales by Company (2019-2024)
      • 3.1.2 Global Dipotassium Glycyrrhizinate Sales Market Share by Company (2019-2024)
    • 3.2 Global Dipotassium Glycyrrhizinate Annual Revenue by Company (2019-2024)
      • 3.2.1 Global Dipotassium Glycyrrhizinate Revenue by Company (2019-2024)
      • 3.2.2 Global Dipotassium Glycyrrhizinate Revenue Market Share by Company (2019-2024)
    • 3.3 Global Dipotassium Glycyrrhizinate Sale Price by Company
    • 3.4 Key Manufacturers Dipotassium Glycyrrhizinate Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Dipotassium Glycyrrhizinate Product Location Distribution
      • 3.4.2 Players Dipotassium Glycyrrhizinate Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for Dipotassium Glycyrrhizinate by Geographic Region

    • 4.1 World Historic Dipotassium Glycyrrhizinate Market Size by Geographic Region (2019-2024)
      • 4.1.1 Global Dipotassium Glycyrrhizinate Annual Sales by Geographic Region (2019-2024)
      • 4.1.2 Global Dipotassium Glycyrrhizinate Annual Revenue by Geographic Region (2019-2024)
    • 4.2 World Historic Dipotassium Glycyrrhizinate Market Size by Country/Region (2019-2024)
      • 4.2.1 Global Dipotassium Glycyrrhizinate Annual Sales by Country/Region (2019-2024)
      • 4.2.2 Global Dipotassium Glycyrrhizinate Annual Revenue by Country/Region (2019-2024)
    • 4.3 Americas Dipotassium Glycyrrhizinate Sales Growth
    • 4.4 APAC Dipotassium Glycyrrhizinate Sales Growth
    • 4.5 Europe Dipotassium Glycyrrhizinate Sales Growth
    • 4.6 Middle East & Africa Dipotassium Glycyrrhizinate Sales Growth
  • 5 Americas

    • 5.1 Americas Dipotassium Glycyrrhizinate Sales by Country
      • 5.1.1 Americas Dipotassium Glycyrrhizinate Sales by Country (2019-2024)
      • 5.1.2 Americas Dipotassium Glycyrrhizinate Revenue by Country (2019-2024)
    • 5.2 Americas Dipotassium Glycyrrhizinate Sales by Type (2019-2024)
    • 5.3 Americas Dipotassium Glycyrrhizinate Sales by Application (2019-2024)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Dipotassium Glycyrrhizinate Sales by Region
      • 6.1.1 APAC Dipotassium Glycyrrhizinate Sales by Region (2019-2024)
      • 6.1.2 APAC Dipotassium Glycyrrhizinate Revenue by Region (2019-2024)
    • 6.2 APAC Dipotassium Glycyrrhizinate Sales by Type (2019-2024)
    • 6.3 APAC Dipotassium Glycyrrhizinate Sales by Application (2019-2024)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Dipotassium Glycyrrhizinate by Country
      • 7.1.1 Europe Dipotassium Glycyrrhizinate Sales by Country (2019-2024)
      • 7.1.2 Europe Dipotassium Glycyrrhizinate Revenue by Country (2019-2024)
    • 7.2 Europe Dipotassium Glycyrrhizinate Sales by Type (2019-2024)
    • 7.3 Europe Dipotassium Glycyrrhizinate Sales by Application (2019-2024)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Dipotassium Glycyrrhizinate by Country
      • 8.1.1 Middle East & Africa Dipotassium Glycyrrhizinate Sales by Country (2019-2024)
      • 8.1.2 Middle East & Africa Dipotassium Glycyrrhizinate Revenue by Country (2019-2024)
    • 8.2 Middle East & Africa Dipotassium Glycyrrhizinate Sales by Type (2019-2024)
    • 8.3 Middle East & Africa Dipotassium Glycyrrhizinate Sales by Application (2019-2024)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Dipotassium Glycyrrhizinate
    • 10.3 Manufacturing Process Analysis of Dipotassium Glycyrrhizinate
    • 10.4 Industry Chain Structure of Dipotassium Glycyrrhizinate
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Dipotassium Glycyrrhizinate Distributors
    • 11.3 Dipotassium Glycyrrhizinate Customer
  • 12 World Forecast Review for Dipotassium Glycyrrhizinate by Geographic Region

    • 12.1 Global Dipotassium Glycyrrhizinate Market Size Forecast by Region
      • 12.1.1 Global Dipotassium Glycyrrhizinate Forecast by Region (2025-2030)
      • 12.1.2 Global Dipotassium Glycyrrhizinate Annual Revenue Forecast by Region (2025-2030)
    • 12.2 Americas Forecast by Country (2025-2030)
    • 12.3 APAC Forecast by Region (2025-2030)
    • 12.4 Europe Forecast by Country (2025-2030)
    • 12.5 Middle East & Africa Forecast by Country (2025-2030)
    • 12.6 Global Dipotassium Glycyrrhizinate Forecast by Type (2025-2030)
    • 12.7 Global Dipotassium Glycyrrhizinate Forecast by Application (2025-2030)
  • 13 Key Players Analysis

    • 13.1 GfN Selco
      • 13.1.1 GfN Selco Company Information
      • 13.1.2 GfN Selco Dipotassium Glycyrrhizinate Product Portfolios and Specifications
      • 13.1.3 GfN Selco Dipotassium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.1.4 GfN Selco Main Business Overview
      • 13.1.5 GfN Selco Latest Developments
    • 13.2 Alps Pharmaceutical
      • 13.2.1 Alps Pharmaceutical Company Information
      • 13.2.2 Alps Pharmaceutical Dipotassium Glycyrrhizinate Product Portfolios and Specifications
      • 13.2.3 Alps Pharmaceutical Dipotassium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.2.4 Alps Pharmaceutical Main Business Overview
      • 13.2.5 Alps Pharmaceutical Latest Developments
    • 13.3 Nikko Chemicals
      • 13.3.1 Nikko Chemicals Company Information
      • 13.3.2 Nikko Chemicals Dipotassium Glycyrrhizinate Product Portfolios and Specifications
      • 13.3.3 Nikko Chemicals Dipotassium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.3.4 Nikko Chemicals Main Business Overview
      • 13.3.5 Nikko Chemicals Latest Developments
    • 13.4 Fanzhi Pharmaceutical
      • 13.4.1 Fanzhi Pharmaceutical Company Information
      • 13.4.2 Fanzhi Pharmaceutical Dipotassium Glycyrrhizinate Product Portfolios and Specifications
      • 13.4.3 Fanzhi Pharmaceutical Dipotassium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.4.4 Fanzhi Pharmaceutical Main Business Overview
      • 13.4.5 Fanzhi Pharmaceutical Latest Developments
    • 13.5 MAFCO Worldwide
      • 13.5.1 MAFCO Worldwide Company Information
      • 13.5.2 MAFCO Worldwide Dipotassium Glycyrrhizinate Product Portfolios and Specifications
      • 13.5.3 MAFCO Worldwide Dipotassium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.5.4 MAFCO Worldwide Main Business Overview
      • 13.5.5 MAFCO Worldwide Latest Developments
    • 13.6 Shaanxi Jintai Biological Engineering
      • 13.6.1 Shaanxi Jintai Biological Engineering Company Information
      • 13.6.2 Shaanxi Jintai Biological Engineering Dipotassium Glycyrrhizinate Product Portfolios and Specifications
      • 13.6.3 Shaanxi Jintai Biological Engineering Dipotassium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.6.4 Shaanxi Jintai Biological Engineering Main Business Overview
      • 13.6.5 Shaanxi Jintai Biological Engineering Latest Developments
    • 13.7 Jiangsu Tiansheng Pharmaceutical
      • 13.7.1 Jiangsu Tiansheng Pharmaceutical Company Information
      • 13.7.2 Jiangsu Tiansheng Pharmaceutical Dipotassium Glycyrrhizinate Product Portfolios and Specifications
      • 13.7.3 Jiangsu Tiansheng Pharmaceutical Dipotassium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.7.4 Jiangsu Tiansheng Pharmaceutical Main Business Overview
      • 13.7.5 Jiangsu Tiansheng Pharmaceutical Latest Developments
    • 13.8 Qinghai Lake Pharmaceutical
      • 13.8.1 Qinghai Lake Pharmaceutical Company Information
      • 13.8.2 Qinghai Lake Pharmaceutical Dipotassium Glycyrrhizinate Product Portfolios and Specifications
      • 13.8.3 Qinghai Lake Pharmaceutical Dipotassium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.8.4 Qinghai Lake Pharmaceutical Main Business Overview
      • 13.8.5 Qinghai Lake Pharmaceutical Latest Developments
    • 13.9 VITAL-CHEM Zhuhai
      • 13.9.1 VITAL-CHEM Zhuhai Company Information
      • 13.9.2 VITAL-CHEM Zhuhai Dipotassium Glycyrrhizinate Product Portfolios and Specifications
      • 13.9.3 VITAL-CHEM Zhuhai Dipotassium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.9.4 VITAL-CHEM Zhuhai Main Business Overview
      • 13.9.5 VITAL-CHEM Zhuhai Latest Developments
    • 13.10 Shaanxi Fujie Pharmaceutical
      • 13.10.1 Shaanxi Fujie Pharmaceutical Company Information
      • 13.10.2 Shaanxi Fujie Pharmaceutical Dipotassium Glycyrrhizinate Product Portfolios and Specifications
      • 13.10.3 Shaanxi Fujie Pharmaceutical Dipotassium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.10.4 Shaanxi Fujie Pharmaceutical Main Business Overview
      • 13.10.5 Shaanxi Fujie Pharmaceutical Latest Developments
    • 13.11 Qingdao Taitong Pharmaceutical
      • 13.11.1 Qingdao Taitong Pharmaceutical Company Information
      • 13.11.2 Qingdao Taitong Pharmaceutical Dipotassium Glycyrrhizinate Product Portfolios and Specifications
      • 13.11.3 Qingdao Taitong Pharmaceutical Dipotassium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.11.4 Qingdao Taitong Pharmaceutical Main Business Overview
      • 13.11.5 Qingdao Taitong Pharmaceutical Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.